Guangzhou Zhiyi Biotechnology Co., Ltd.

广州知易生物科技股份有限公司

Clinical-stage biopharmaceutical company developing live biotherapeutic products (LBPs) for gastrointestinal diseases, oncology, cancer therapy-related complications, metabolic, and autoimmune diseases, established in 2013.

Filings

The documents are on HKEXnews; we link to the originals.

Matters the filing discloses

From the company’s latest filing; open a kind of matter to see how other companies disclosed it.

• Customer concentration
• Supplier concentration
• Overlapping customers and suppliers
• Connected or related major customers / suppliers
• Distribution model
• Outsourced production (OEM / contract manufacturing)
• Particular sales arrangements
• Business changes and acquisitions
• Capacity and utilisation
• Negative operating cash flow
• Cash burn and runway
• Non-recurring gains and losses
• Related-party transactions and balances
• Chapter 18A biotech
• Other